NR 546 WEEK 8 FINAL EXAM COMPLETE QUESTIONS
1-75 ACTUAL EXAM SCREENSHOTS 29 AUGUST 2025
EXAMPLIFY PROCTORED NR546 ADVANCED
PSYCHOPHARMACOLOGY FOR THE PMHNP EXAM
QUESTIONS AND ANSWERS
CORE DOMAINS
Neurotransmitters and Receptors
Antidepressants: SSRIs, SNRIs, MAOIs, TCAs
Antipsychotics: Typical and Atypical
Mood Stabilizers and Anxiolytics
ADHD Medications and Stimulants
Substance Use Disorder Pharmacotherapy
Special Populations and Adverse Effects
Pharmacogenomics and Drug Interactions
Neurobiology of Addiction and Reward Pathways
Ethical and Regulatory Prescribing Considerations
INTRODUCTION
This comprehensive final examination assesses the advanced
psychopharmacology knowledge and clinical decision-making skills
required of the psychiatric-mental health nurse practitioner. It evaluates
foundational neurotransmitter mechanisms, receptor pharmacology, and
the therapeutic application of psychotropic medications across the lifespan.
The examination employs multiple-choice and scenario-based questions to
simulate realistic clinical encounters. Emphasis is placed on critical
thinking, mechanism-based reasoning, adverse effect monitoring, and the
application of evidence-based psychopharmacology in diverse patient
populations. This assessment prepares candidates for the rigor of
advanced practice certification and real-world clinical practice.
SECTION ONE: QUESTIONS 1–75
1. A drug that acts as an inverse agonist at a receptor will:
,A. Produce the same effect as a neutral antagonist
B. Stabilize the receptor in its inactive state, reducing constitutive activity
C. Block the receptor without affecting baseline activity
D. Activate the receptor to a greater degree than a full agonist
B. Stabilize the receptor in its inactive state, reducing constitutive
activity
RATIONALE: An inverse agonist stabilizes a receptor in its inactive
conformation, reducing the baseline (constitutive) activity of the receptor. A
neutral antagonist simply blocks agonist binding without affecting
constitutive activity, while a full agonist produces maximum activation.
2. The therapeutic effect of selective serotonin reuptake inhibitors
(SSRIs) is primarily mediated by:
A. Upregulation of postsynaptic 5-HT2A receptors
B. Downregulation of presynaptic autoreceptors and desensitization
C. Immediate increase in synaptic serotonin
D. Antagonism of norepinephrine transporters
B. Downregulation of presynaptic autoreceptors and desensitization
RATIONALE: While SSRIs immediately increase synaptic serotonin, the
therapeutic lag (2-4 weeks) is due to the time required for presynaptic 5-
HT1A autoreceptors to desensitize, allowing for sustained serotonergic
transmission.
3. Which of the following is considered the "pleasure center" of the
brain?
A. Cortico-striatal-thalamic-cortical loop
B. Mesolimbic dopamine pathway
C. Mesocortical dopamine pathway
D. Nigrostriatal pathway
B. Mesolimbic dopamine pathway
RATIONALE: The mesolimbic dopamine pathway, which projects from
the ventral tegmental area (VTA) to the nucleus accumbens, is considered
, the brain's "pleasure center" and is critically involved in reward, motivation,
and the reinforcing effects of drugs of abuse.
4. The reactive reward system signals the immediate prospect of
pleasure or pain and triggers drug-seeking behavior.
A. True
B. False
A. True
RATIONALE: The reactive reward system is responsible for immediate
responses to rewarding or aversive stimuli and plays a key role in triggering
drug-seeking behavior.
5. What role does the amygdala play in substance abuse?
A. Releases phasic bursts of dopamine to the nucleus accumbens when
drugs of abuse are present
B. Communicates to the ventral tegmental area when cues related to drugs
of abuse are present
C. Site of binding for most drugs of abuse
D. A and B
B. Communicates to the ventral tegmental area when cues related to
drugs of abuse are present
RATIONALE: The amygdala communicates with the ventral tegmental
area (VTA) when cues related to drugs of abuse are present, playing a
critical role in conditioned responses and craving triggered by
environmental stimuli.
6. Transport of monoamines requires energy, which is supplied by:
A. Calcium pump
B. Potassium pump
C. Sodium pump
D. Magnesium pump
C. Sodium pump
RATIONALE: The transport of monoamines (serotonin, dopamine,
1-75 ACTUAL EXAM SCREENSHOTS 29 AUGUST 2025
EXAMPLIFY PROCTORED NR546 ADVANCED
PSYCHOPHARMACOLOGY FOR THE PMHNP EXAM
QUESTIONS AND ANSWERS
CORE DOMAINS
Neurotransmitters and Receptors
Antidepressants: SSRIs, SNRIs, MAOIs, TCAs
Antipsychotics: Typical and Atypical
Mood Stabilizers and Anxiolytics
ADHD Medications and Stimulants
Substance Use Disorder Pharmacotherapy
Special Populations and Adverse Effects
Pharmacogenomics and Drug Interactions
Neurobiology of Addiction and Reward Pathways
Ethical and Regulatory Prescribing Considerations
INTRODUCTION
This comprehensive final examination assesses the advanced
psychopharmacology knowledge and clinical decision-making skills
required of the psychiatric-mental health nurse practitioner. It evaluates
foundational neurotransmitter mechanisms, receptor pharmacology, and
the therapeutic application of psychotropic medications across the lifespan.
The examination employs multiple-choice and scenario-based questions to
simulate realistic clinical encounters. Emphasis is placed on critical
thinking, mechanism-based reasoning, adverse effect monitoring, and the
application of evidence-based psychopharmacology in diverse patient
populations. This assessment prepares candidates for the rigor of
advanced practice certification and real-world clinical practice.
SECTION ONE: QUESTIONS 1–75
1. A drug that acts as an inverse agonist at a receptor will:
,A. Produce the same effect as a neutral antagonist
B. Stabilize the receptor in its inactive state, reducing constitutive activity
C. Block the receptor without affecting baseline activity
D. Activate the receptor to a greater degree than a full agonist
B. Stabilize the receptor in its inactive state, reducing constitutive
activity
RATIONALE: An inverse agonist stabilizes a receptor in its inactive
conformation, reducing the baseline (constitutive) activity of the receptor. A
neutral antagonist simply blocks agonist binding without affecting
constitutive activity, while a full agonist produces maximum activation.
2. The therapeutic effect of selective serotonin reuptake inhibitors
(SSRIs) is primarily mediated by:
A. Upregulation of postsynaptic 5-HT2A receptors
B. Downregulation of presynaptic autoreceptors and desensitization
C. Immediate increase in synaptic serotonin
D. Antagonism of norepinephrine transporters
B. Downregulation of presynaptic autoreceptors and desensitization
RATIONALE: While SSRIs immediately increase synaptic serotonin, the
therapeutic lag (2-4 weeks) is due to the time required for presynaptic 5-
HT1A autoreceptors to desensitize, allowing for sustained serotonergic
transmission.
3. Which of the following is considered the "pleasure center" of the
brain?
A. Cortico-striatal-thalamic-cortical loop
B. Mesolimbic dopamine pathway
C. Mesocortical dopamine pathway
D. Nigrostriatal pathway
B. Mesolimbic dopamine pathway
RATIONALE: The mesolimbic dopamine pathway, which projects from
the ventral tegmental area (VTA) to the nucleus accumbens, is considered
, the brain's "pleasure center" and is critically involved in reward, motivation,
and the reinforcing effects of drugs of abuse.
4. The reactive reward system signals the immediate prospect of
pleasure or pain and triggers drug-seeking behavior.
A. True
B. False
A. True
RATIONALE: The reactive reward system is responsible for immediate
responses to rewarding or aversive stimuli and plays a key role in triggering
drug-seeking behavior.
5. What role does the amygdala play in substance abuse?
A. Releases phasic bursts of dopamine to the nucleus accumbens when
drugs of abuse are present
B. Communicates to the ventral tegmental area when cues related to drugs
of abuse are present
C. Site of binding for most drugs of abuse
D. A and B
B. Communicates to the ventral tegmental area when cues related to
drugs of abuse are present
RATIONALE: The amygdala communicates with the ventral tegmental
area (VTA) when cues related to drugs of abuse are present, playing a
critical role in conditioned responses and craving triggered by
environmental stimuli.
6. Transport of monoamines requires energy, which is supplied by:
A. Calcium pump
B. Potassium pump
C. Sodium pump
D. Magnesium pump
C. Sodium pump
RATIONALE: The transport of monoamines (serotonin, dopamine,
